CABIOĞLU, N. Et Al. 2021. Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study. EJSO , vol.47, no.10 , 2506-2514.

CABIOĞLU, N., KARANLIK, H., Yildirim, N., MÜSLÜMANOĞLU, M. E., Karadeniz, G. C., Can, D. T., ... TÜKENMEZ, M.(2021). Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study. EJSO , vol.47, no.10, 2506-2514.

CABIOĞLU, Neslihan Et Al. "Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study," EJSO , vol.47, no.10, 2506-2514, 2021

CABIOĞLU, Neslihan Et Al. "Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study." EJSO , vol.47, no.10, pp.2506-2514, 2021

CABIOĞLU, N. Et Al. (2021) . "Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study." EJSO , vol.47, no.10, pp.2506-2514.

@article{article, author={Neslihan CABIOĞLU Et Al. }, title={Favorable outcome with sentinel lymph node biopsy alone after neoadjuvant chemotherapy in clinically node positive breast cancer at diagnosis: Turkish Multicentric NEOSENTI-TURK MF-18-02-study}, journal={EJSO}, year=2021, pages={2506-2514} }